Zobrazeno 1 - 10
of 209
pro vyhledávání: '"David C. Kaslow"'
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-3 (2024)
Abstract In August 2023, FDA approved Abrysvo for active immunization of pregnant individuals at 32 through 36 weeks gestational age to prevent lower respiratory tract disease (LRTD), including severe LRTD, caused by respiratory syncytial virus (RSV)
Externí odkaz:
https://doaj.org/article/b1c082fe06f04592bb451be24cb56ade
Autor:
Deborah F. King, Helen Groves, Charlie Weller, Ian Jones, Jakob P. Cramer, Peter B. Gilbert, David Goldblatt, Marion F. Gruber, Beate Kampmann, Diadié Maïga, Marcela F. Pasetti, Stanley A. Plotkin, Alexander Precioso, Liya Wassie, Frederick Wittke, David C. Kaslow
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
On 27–29th of September 2022, Wellcome convened an international multi-stakeholder workshop to discuss the use of Correlates of Protection (CoP) to accelerate vaccine development, the hybrid format meeting was attended by 80 delegates including dev
Externí odkaz:
https://doaj.org/article/b667f597503a47e59f0908a1ed984fa8
Autor:
Corey Casper, Lawrence Corey, Jeffrey I. Cohen, Blossom Damania, Anne A. Gershon, David C. Kaslow, Laurie T. Krug, Jeffrey Martin, Sam M. Mbulaiteye, Edward S. Mocarski, Patrick S. Moore, Javier Gordon Ogembo, Warren Phipps, Denise Whitby, Charles Wood
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-10 (2022)
Abstract Seven viruses cause at least 15% of the total cancer burden. Viral cancers have been described as the “low-hanging fruit” that can be potentially prevented or treated by new vaccines that would alter the course of global human cancer. Ka
Externí odkaz:
https://doaj.org/article/87a2b5efaf4c48b2bde92d3d10e467a0
Autor:
David C. Kaslow
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-7 (2021)
Abstract Vaccine efficacy (VE) can vary in different settings. Of the many proposed setting-dependent determinants of VE, force of infection (FoI) stands out as one of the most direct, proximate, and actionable. As highlighted by the COVID-19 pandemi
Externí odkaz:
https://doaj.org/article/66616f8e1eff4f78914611366ca5864a
Autor:
Lorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittamala, Pongphaya Pongsuwan, Kesinee Chotivanich, Joel Tarning, Richard M. Hoglund, Markus Winterberg, Mavuto Mukaka, Pimnara Peerawaranun, Pasathorn Sirithiranont, Zoe Doran, Christian F. Ockenhouse, Karen Ivinson, Cynthia Lee, Ashley J. Birkett, David C. Kaslow, Pratap Singhasivanon, Nicholas P.J. Day, Arjen M. Dondorp, Nicholas J. White, Sasithon Pukrittayakamee
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 1, Pp 33-41 (2020)
Introduction: RTS,S/AS01 is currently the most advanced malaria vaccine but provides incomplete, short-term protection. It was developed for use within the expanded program on immunizations (EPI) for African children. Another use could be adding mass
Externí odkaz:
https://doaj.org/article/10658784ace14906a79c8aa180809379
Autor:
Peter J. Hotez, Carolina Batista, Yanis Ben Amor, Onder Ergonul, J Peter Figueroa, Sarah Gilbert, Mayda Gursel, Mazen Hassanain, Gagandeep Kang, David C. Kaslow, Jerome H. Kim, Bhavna Lall, Heidi Larson, Denise Naniche, Timothy Sheahan, Shmuel Shoham, Annelies Wilder-Smith, Samba O. Sow, Nathalie Strub-Wourgaft, Prashant Yadav, Maria Elena Bottazzi
Publikováno v:
EClinicalMedicine, Vol 39, Iss , Pp 101053- (2021)
A Lancet Commission for COVID-19 task force is shaping recommendations to achieve vaccine and therapeutics access, justice, and equity. This includes ensuring safety and effectiveness harmonized through robust systems of global pharmacovigilance and
Externí odkaz:
https://doaj.org/article/29b5d07e57514beda7339fe8fcbc2397
Autor:
Chris Drakeley, Salim Abdulla, Selidji Todagbe Agnandji, José Francisco Fernandes, Peter Kremsner, Bertrand Lell, Ludovic Mewono, Bache Emmanuel Bache, Michael Gabriel Mihayo, Omar Juma, Marcel Tanner, Marc Christian Tahita, Halidou Tinto, Salou Diallo, Palpouguini Lompo, Umberto D’Alessandro, Bernhards Ogutu, Lucas Otieno, Solomon Otieno, Walter Otieno, Janet Oyieko, Kwaku Poku Asante, Dominic Bon-Ereme Dery, George Adjei, Elisha Adeniji, Dorcas Atibilla, Seth Owusu-Agyei, Brian Greenwood, Samwel Gesase, John Lusingu, Coline Mahende, Robert Mongi, Method Segeja, Samuel Adjei, Tsiri Agbenyega, Alex Agyekum, Daniel Ansong, John Tanko Bawa, Harry Owusu Boateng, Léonard Dandalo, Veronica Escamilla, Irving Hoffman, Peter Maenje, Francis Martinson, Terrell Carter, Didier Leboulleux, David C. Kaslow, Effua Usuf, Jean-Yves Pirçon, Edith Roset Bahmanyar
Publikováno v:
Malaria Journal, Vol 16, Iss 1, Pp 1-15 (2017)
Abstract Background Plasmodium falciparum prevalence (PfPR) is a widely used metric for assessing malaria transmission intensity. This study was carried out concurrently with the RTS,S/AS01 candidate malaria vaccine Phase III trial and estimated PfPR
Externí odkaz:
https://doaj.org/article/6e058e429cf64226b67c39b4bafbf55f
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 89, Iss 2, Pp 279-295 (1994)
Externí odkaz:
https://doaj.org/article/92a5d7f5c6414f59b43608f6b93e0356
Autor:
David C. Kaslow, Ivan C. Bathurst, Stuart N. Isaacs, David B. Keister, Bernard Moss, Philip J. Barr
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 87, Pp 175-177 (1992)
Externí odkaz:
https://doaj.org/article/d81f744167da4b2389a1c97f8f3a09fa
Autor:
David C Kaslow, Carolina Batista, Maria Elena Bottazzi, Onder Ergonul, J Peter Figueroa, Mayda Gursel, Mazen Hassanain, Peter Hotez, Gagandeep Kang, Bhavna Lall, Heidi Larson, Denise Naniche, Timothy Sheahan, Samba O Sow, Nathalie Strub-Wourgaft, Prashant Yadav, Annelies Wilder-Smith
Publikováno v:
Vaccine Insights. :213-218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afdfb8ee59e5b2c854fb1a8cb12698d1
https://doi.org/10.18609/vac.2022.32
https://doi.org/10.18609/vac.2022.32